These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26153653)

  • 1. Allergen stability of testing/treatment boards and immunotherapy vials with various diluents.
    Nida A; Leatherman B; Plunkett G; Mire B
    Int Forum Allergy Rhinol; 2015 Nov; 5(11):1028-35. PubMed ID: 26153653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The GILL study: glycerin-induced local reactions in immunotherapy.
    Calabria CW; Coop CA; Tankersley MS
    J Allergy Clin Immunol; 2008 Jan; 121(1):222-6. PubMed ID: 17919703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allergen immunotherapy practice in the United States: guidelines, measures, and outcomes.
    Cox L; Esch RE; Corbett M; Hankin C; Nelson M; Plunkett G
    Ann Allergy Asthma Immunol; 2011 Oct; 107(4):289-99; quiz 300. PubMed ID: 21962088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update: stability of allergen extracts to establish expiration dating.
    Plunkett G
    Curr Opin Otolaryngol Head Neck Surg; 2016 Jun; 24(3):261-9. PubMed ID: 27092907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stability of allergen extracts used in skin testing and immunotherapy.
    Plunkett G
    Curr Opin Otolaryngol Head Neck Surg; 2008 Jun; 16(3):285-91. PubMed ID: 18475087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Allergen stabilities and compatibilities in mixtures of high-protease fungal and insect extracts.
    Grier TJ; LeFevre DM; Duncan EA; Esch RE; Coyne TC
    Ann Allergy Asthma Immunol; 2012 Jun; 108(6):439-47. PubMed ID: 22626598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors influencing the quality of Myrmecia pilosula (Jack Jumper) ant venom for use in in vitro and in vivo diagnoses of allergen sensitization and in allergen immunotherapy.
    Wanandy T; Dwyer HE; McLean L; Davies NW; Nichols D; Gueven N; Brown SGA; Wiese MD
    Clin Exp Allergy; 2017 Nov; 47(11):1478-1490. PubMed ID: 28756642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How's my dosing? A one-step, math-free guide for comparing your clinic's maintenance immunotherapy doses to current practice parameter recommendations.
    Grier TJ
    Ann Allergy Asthma Immunol; 2012 Mar; 108(3):201-5. PubMed ID: 22374205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Math-free guides for glycerin and allergens at variable subcutaneous injection volumes: How's my dosing? Update.
    Grier TJ; Converse LM; Rekkerth DJ; Renahan KE
    Ann Allergy Asthma Immunol; 2016 May; 116(5):455-60. PubMed ID: 27017565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mixing compatibilities of Aspergillus and American cockroach allergens with other high-protease fungal and insect extracts.
    Grier TJ; Hall DM; Duncan EA; Coyne TC
    Ann Allergy Asthma Immunol; 2015 Mar; 114(3):233-9. PubMed ID: 25578248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific immunotherapy with allergen mixes: what is the evidence?
    Nelson HS
    Curr Opin Allergy Clin Immunol; 2009 Dec; 9(6):549-53. PubMed ID: 19745727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of palatability of two sublingual diluents in allergic patients: a prospective pilot study.
    Nguyen SA; Schlosser RJ
    Am J Rhinol Allergy; 2011; 25(5):342-5. PubMed ID: 21639998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standardization of allergen-specific immunotherapy vaccines.
    Spangfort MD; Larsen JN
    Immunol Allergy Clin North Am; 2006 May; 26(2):191-206, v-vi. PubMed ID: 16701140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of recombinant and native timothy pollen (rPhl p 1, 2, 5, 6, 7, 11, 12 and nPhl p 4)- specific IgG4 antibodies induced by subcutaneous immunotherapy with timothy pollen extract in allergic patients.
    Rossi RE; Monasterolo G
    Int Arch Allergy Immunol; 2004 Sep; 135(1):44-53. PubMed ID: 15286445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple-allergen and single-allergen immunotherapy strategies in polysensitized patients: looking at the published evidence.
    Calderón MA; Cox L; Casale TB; Moingeon P; Demoly P
    J Allergy Clin Immunol; 2012 Apr; 129(4):929-34. PubMed ID: 22244595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Allergen stabilities and compatibilities in immunotherapy mixtures that contain cat, dog, dust mite, and cockroach extracts.
    Grier TJ; Hall DM; Duncan EA; Gada SM
    Ann Allergy Asthma Immunol; 2015 Dec; 115(6):496-502. PubMed ID: 26522255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allergen-specific immunosuppression by ovalbumin fused with diphtheria toxin in mice sensitized with albumins of different origin.
    Lee BK; Yoo JE; Jang YS; Kim JY; Hong CS; Ro JY
    Clin Exp Allergy; 2004 Oct; 34(10):1642-8. PubMed ID: 15479282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammalian-derived respiratory allergens - implications for diagnosis and therapy of individuals allergic to furry animals.
    Nilsson OB; van Hage M; Grönlund H
    Methods; 2014 Mar; 66(1):86-95. PubMed ID: 24041755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T-cell responses during allergen-specific immunotherapy.
    Maggi E; Vultaggio A; Matucci A
    Curr Opin Allergy Clin Immunol; 2012 Feb; 12(1):1-6. PubMed ID: 22157159
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.